Cargando…

Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of Prognosis

Lung cancer is still the major contributor to cancer-related mortality. Over 85% of patients suffer from non-small-cell lung cancer (NSCLC). Mucins (MUCs) are large glycoproteins secreted or membrane-bound produced by epithelial cells in normal and malignant tissues. They are the major components of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Jing, Tang, Min, Li, Guoqing, Chen, Liang, Wang, Yubo, Huang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439898/ https://www.ncbi.nlm.nih.gov/pubmed/36059804 http://dx.doi.org/10.1155/2022/4181658

Ejemplares similares

Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma
por: Tang, Min, et al.
Publicado: (2022)

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis
por: Shinohara, Shuichi, et al.
Publicado: (2022)

Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma
por: Tu, Jing, et al.
Publicado: (2022)

Expression of the Cavin Family in Childhood Leukemia and Its Implications in Subtype Diagnosis and Prognosis Evaluation
por: Yang, Jing, et al.
Publicado: (2022)

Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer
por: Wang, Jianglin, et al.
Publicado: (2022)

Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status
por: Linhas, Rita, et al.
Publicado: (2017)

Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
por: Wang, Shunda, et al.
Publicado: (2020)

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis
por: Alifu, Muyesar, et al.
Publicado: (2023)

Prognosis of early mucinous gastric carcinoma
por: Ryu, Seong Yeob, et al.
Publicado: (2014)

First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments
por: Nie, Naifu, et al.
Publicado: (2022)

Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
por: Park, Ji Eun, et al.
Publicado: (2020)

Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery
por: Sun, Zhi-Gang, et al.
Publicado: (2018)

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer
por: Qi, Lei, et al.
Publicado: (2014)

Clinicopathological Characteristics and Prognosis of Non-Small Cell Lung Cancer Patients Associated with a Family History of Lung Cancer
por: Haraguchi, Shuji, et al.
Publicado: (2011)

hsa_circ_0072309 Expression Profiling in Non-small-Cell Lung Carcinoma and Its Implications for Diagnosis and Prognosis
por: Zhou, Yong, et al.
Publicado: (2022)

The potential of high-order features of routine blood test in predicting the prognosis of non-small cell lung cancer
por: Luo, Liping, et al.
Publicado: (2023)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Radiomics-Clinical AI Model with Probability Weighted Strategy for Prognosis Prediction in Non-Small Cell Lung Cancer
por: Tang, Fuk-Hay, et al.
Publicado: (2023)

Association between overexpression of Wip1 and prognosis of patients with non-small cell lung cancer
por: ZHAO, MIN, et al.
Publicado: (2016)

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
por: Micke, Patrick, et al.
Publicado: (2019)

Molecular gene signature and prognosis of non-small cell lung cancer
por: Huang, Poyin, et al.
Publicado: (2016)

The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2023)

BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
por: Cai, Deng, et al.
Publicado: (2014)

Mucins: the frontline defence of the lung
por: Ridley, Caroline, et al.
Publicado: (2018)

Invasive mucinous adenocarcinoma of the lung
por: Xu, Lu, et al.
Publicado: (2019)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis
por: Chen, Jinghua, et al.
Publicado: (2020)

Platelet distribution width correlates with prognosis of non-small cell lung cancer
por: Cui, Ming-ming, et al.
Publicado: (2017)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
por: Sun, Fei, et al.
Publicado: (2018)

Appendiceal Mucinous Neoplasms: From Clinic to Pathology and Prognosis
por: González Bayón, Luis, et al.
Publicado: (2023)

Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer
por: Jiang, Li-Peng, et al.
Publicado: (2016)

Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer
por: Fan, Yongfei, et al.
Publicado: (2021)

Correction: BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer
por: Huang, He, et al.
Publicado: (2019)

Identification of key differentially expressed genes associated with non-small cell lung cancer by bioinformatics analyses
por: Xiao, Yubo, et al.
Publicado: (2018)

Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
por: Xu, Yu-Hua, et al.
Publicado: (2019)

Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers
por: Song, Zhengbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r5dn96r27i2hvu7sbo5j2rjs0f